Item Type | Name |
Academic Article
|
Construction and characterization of molecular clones containing integrated mouse mammary tumor virus sequences.
|
Academic Article
|
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.
|
Academic Article
|
p53 deficiency does not affect the accumulation of point mutations in a transgene target.
|
Academic Article
|
Transgenic mouse models for tumour-suppressor genes.
|
Academic Article
|
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.
|
Academic Article
|
A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice.
|
Academic Article
|
Gene-targeting and the p53 tumor-suppressor gene.
|
Academic Article
|
Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients.
|
Academic Article
|
Androgen suppressed apoptosis is modified in p53 deficient mice.
|
Academic Article
|
Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
|
Academic Article
|
Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype.
|
Academic Article
|
Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome.
|
Academic Article
|
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.
|
Academic Article
|
p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes.
|
Academic Article
|
Effects of genetic background on tumorigenesis in p53-deficient mice.
|
Academic Article
|
Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas.
|
Academic Article
|
Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?
|
Academic Article
|
Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death.
|
Academic Article
|
Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
|
Academic Article
|
Genomic organization of the mouse double minute 2 gene.
|
Academic Article
|
The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.
|
Academic Article
|
Decreased immunoglobulin deposition in tumors and increased immature B cells in p53-null mice.
|
Academic Article
|
Transgenic animals in toxicology.
|
Academic Article
|
Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice.
|
Academic Article
|
In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.
|
Academic Article
|
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.
|
Academic Article
|
Genetic background alters the spectrum of tumors that develop in p53-deficient mice.
|
Academic Article
|
The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene.
|
Academic Article
|
Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.
|
Academic Article
|
Effects of p53 mutation on tumor progression: recent insights from mouse tumor models.
|
Academic Article
|
The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.
|
Academic Article
|
p53 in embryonic development: maintaining a fine balance.
|
Academic Article
|
Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control.
|
Academic Article
|
The p53-deficient mouse: a model for basic and applied cancer studies.
|
Academic Article
|
Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis.
|
Academic Article
|
Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination.
|
Academic Article
|
Effect of intragastric application of N-methylnitrosourea in p53 knockout mice.
|
Academic Article
|
Cooperation between Ha-ras and fos or transforming growth factor alpha overcomes a paradoxic tumor-inhibitory effect of p53 loss in transgenic mouse epidermis.
|
Academic Article
|
Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.
|
Academic Article
|
Functional analysis of tumor suppressor genes in mice.
|
Academic Article
|
Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.
|
Academic Article
|
Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers.
|
Academic Article
|
Suppression of thymic lymphomas and increased nonthymic lymphomagenesis in Trp53-deficient mice lacking inducible nitric oxide synthase gene.
|
Academic Article
|
Reduction in p53 gene dosage diminishes differentiation capacity of osteoblasts.
|
Academic Article
|
Does p53 affect organismal aging?
|
Academic Article
|
p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis.
|
Academic Article
|
The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.
|
Academic Article
|
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
|
Academic Article
|
Probing p53 biological functions through the use of genetically engineered mouse models.
|
Academic Article
|
Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.
|
Academic Article
|
Transgenic tumor models for carcinogen identification: the heterozygous Trp53-deficient and RasH2 mouse lines.
|
Academic Article
|
The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging.
|
Academic Article
|
Generation and characterization of p53 mutant mice.
|
Academic Article
|
The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair.
|
Academic Article
|
Homeostatic regulation of base excision repair by a p53-induced phosphatase: linking stress response pathways with DNA repair proteins.
|
Academic Article
|
Lack of elevated liver carcinogenicity of aminophenylnorharman in p53-deficient mice.
|
Academic Article
|
Notch signaling contributes to the pathogenesis of human osteosarcomas.
|
Academic Article
|
MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.
|
Academic Article
|
Altered senescence, apoptosis, and DNA damage response in a mutant p53 model of accelerated aging.
|
Academic Article
|
Widespread and tissue specific age-related DNA methylation changes in mice.
|
Academic Article
|
Insights into aging obtained from p53 mutant mouse models.
|
Academic Article
|
P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis.
|
Academic Article
|
The utility of genetically altered mouse models for cancer research.
|
Academic Article
|
Organ-specific susceptibility of p53 knockout mice to N-bis(2-hydroxypropyl)nitrosamine carcinogenesis.
|
Academic Article
|
Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor.
|
Academic Article
|
Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34.
|
Academic Article
|
Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation.
|
Academic Article
|
DeltaNp63alpha overexpression induces downregulation of Sirt1 and an accelerated aging phenotype in the mouse.
|
Academic Article
|
The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
|
Academic Article
|
Altered mammary gland development in the p53+/m mouse, a model of accelerated aging.
|
Academic Article
|
Early development of histiocytic sarcomas in p53 knockout mice treated with N-bis(2-hydroxypropyl)nitrosamine.
|
Academic Article
|
Analysis of cellular senescence in culture in vivo: the senescence-associated beta-galactosidase assay.
|
Academic Article
|
Exercise effects on tumorigenesis in a p53-deficient mouse model of breast cancer.
|
Academic Article
|
Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression.
|
Academic Article
|
20 years studying p53 functions in genetically engineered mice.
|
Academic Article
|
Wild-type p53-induced phosphatase 1 dephosphorylates histone variant gamma-H2AX and suppresses DNA double strand break repair.
|
Academic Article
|
Longevity regulation in flies: a role for p53.
|
Academic Article
|
The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair.
|
Academic Article
|
Using mice to examine p53 functions in cancer, aging, and longevity.
|
Academic Article
|
Mdm2-p53 signaling regulates epidermal stem cell senescence and premature aging phenotypes in mouse skin.
|
Academic Article
|
Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models.
|
Academic Article
|
Absence of Wip1 partially rescues Atm deficiency phenotypes in mice.
|
Academic Article
|
Transcriptional and translational regulation of C/EBP?-HDAC1 protein complexes controls different levels of p53, SIRT1, and PGC1a proteins at the early and late stages of liver cancer.
|
Academic Article
|
The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
|
Academic Article
|
Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.
|
Academic Article
|
Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis.
|
Academic Article
|
Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice.
|
Academic Article
|
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
|
Academic Article
|
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.
|
Academic Article
|
Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation.
|
Academic Article
|
The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model.
|
Academic Article
|
Genetic instability in animal tumorigenesis models.
|
Academic Article
|
Murine tumor suppressor models.
|
Academic Article
|
Mouse models in tumor suppression.
|
Academic Article
|
Increased tumor cell proliferation in murine tumors with decreasing dosage of wild-type p53.
|
Academic Article
|
Heterozygosity of p21WAF1/CIP1 enhances tumor cell proliferation and cyclin D1-associated kinase activity in a murine mammary cancer model.
|
Academic Article
|
Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression.
|
Academic Article
|
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.
|
Academic Article
|
Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
|
Academic Article
|
Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing.
|
Academic Article
|
p53 mutant mice that display early ageing-associated phenotypes.
|
Academic Article
|
High susceptibility of nullizygous p53 knockout mice to colorectal tumor induction by 1,2-dimethylhydrazine.
|
Academic Article
|
Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
|
Academic Article
|
Diet-gene interactions in p53-deficient mice: insulin-like growth factor-1 as a mechanistic target.
|
Academic Article
|
Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice.
|
Academic Article
|
Oxidative and nitrative stress caused by subcutaneous implantation of a foreign body accelerates sarcoma development in Trp53+/- mice.
|
Academic Article
|
Organ-dependent susceptibility of p53 knockout mice to 2-amino-3-methylimidazo[4,5-f]quinoline (IQ).
|
Academic Article
|
Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity.
|
Academic Article
|
Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice.
|
Academic Article
|
Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.
|
Concept
|
Mammary Tumor Virus, Mouse
|
Concept
|
Mice, Inbred CBA
|
Concept
|
Mice, Knockout
|
Concept
|
Mice, Inbred NOD
|
Concept
|
Mice, Inbred BALB C
|
Concept
|
Mice, Nude
|
Concept
|
Mice, SCID
|
Concept
|
Mice, Inbred Strains
|
Concept
|
Mice
|
Concept
|
Mice, Mutant Strains
|
Concept
|
Mice, Inbred ICR
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Mice, Transgenic
|
Academic Article
|
REG? deficiency promotes premature aging via the casein kinase 1 pathway.
|
Academic Article
|
Insights into wild-type and mutant p53 functions provided by genetically engineered mice.
|
Academic Article
|
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53.
|
Academic Article
|
Notch activation as a driver of osteogenic sarcoma.
|
Academic Article
|
NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma.
|
Academic Article
|
Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.
|
Academic Article
|
Ghrelin Prevents Cisplatin-Induced Testicular Damage by Facilitating Repair of DNA Double Strand Breaks Through Activation of p53 in Mice.
|
Academic Article
|
Coamplification of Myc/Pvt1 and homozygous deletion of Nlrp1 locus are frequent genetics changes in mouse osteosarcoma.
|
Academic Article
|
Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.
|
Academic Article
|
Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
|
Academic Article
|
miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.
|
Academic Article
|
Enhanced inflammation and attenuated tumor suppressor pathways are associated with oncogene-induced lung tumors in aged mice.
|
Academic Article
|
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy.
|
Grant
|
P53 AND GENOMIC INSTABILITY MODELS
|
Grant
|
INACTIVATED P53 GENE IN MICE
|
Grant
|
The effects of Age on Cancer Signaling Pathways in Mice
|
Grant
|
Biology of Aging Training Grant
|
Grant
|
P53 and Organismal Aging
|
Grant
|
ROLE OF VIRUS AND CELL GENES IN RETROVIRUS REPLICATION
|
Grant
|
Oncogenic Function of a P53-Induced Phosphatase
|
Grant
|
FURTHER ANALYSIS OF THE P53-DEFICIENT MOUSE
|
Concept
|
Mice, 129 Strain
|
Academic Article
|
K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications.
|